Consolidated Statement of Operations - USD ($)	12 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Details
Revenues	$ 15,046,149	$ 14,817,799
Cost of expenses:
Cost of revenues	8,368,025	10,481,134
Research and development expenses	556,261	593,708
Selling, general, and administrative expenses	9,253,583	8,887,985
Operating Expenses	18,177,869	19,962,827
Loss from operations	(3,131,720)	(5,145,028)
Interest expense - related party	715,933	335,948
Other Loss	0	(1,224)
Loss before income taxes	(3,847,653)	(5,479,752)
(Benefit)/Provision for income taxes	(10,320)	4,634
Net loss	$ (3,837,333)	$ (5,484,386)
Net loss per common share - basic	$ (0.50)	$ (0.71)
Net loss per common share - diluted	$ (0.50)	$ (0.71)
Weighted average number of common shares outstanding - basic	7,696,091	7,696,091
Weighted average number of common shares outstanding - diluted	7,696,091	7,696,091